This stock has soared more than 600% this year.

Wall Street is quite bullish on BioNTech. In fact, among the 20 analysts covering it, 13 rate the stock a strong buy, while ...

A Danish university has approved a CDC-funded study in African newborns, in which only half of babies will receive the ...

By Michael Erman and Julie Steenhuysen NEW YORK, Oct 20 (Reuters) - Doctors are urging Americans aged 6 months and older to ...

The FDA-approved, new mRNA flu shot is now available for adults 50 and older. HealthLink explores how it stacks up against ...

On October 19, 2026, Shah Capital Fund LLC disclosed the sale of 2.87 million shares worth approximately $32.6 million, withdrew its registration as an investment adviser with the SEC, and ...

Julia evolved from an MIT research project into a global open-source programming language. Designed for high-performance scientific computing, it now supports applications across research, engineering ...

This festive season, NH Collection Dubai The Palm is turning Palm Jumeirah into the setting for a celebration filled with ...

As temperatures drop, Sarood Hospitality has revealed a packed events calendar for friends, families, and four-legged ...

Oct 16 (Reuters) - Shah Capital, one of Novavax's top shareholders, said on Friday it no longer seeks to influence control of the vaccine maker after restructuring into a family office.

MAHE hosted the 2nd Nature Conference in India on infectious diseases, covering antimicrobial resistance, TB diagnosis, ...

WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) has approved the country’s first mRNA-based influenza vaccine, developed by Moderna. The vaccine is approved for adults aged 50 to 64 and ...